Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by RjM2018on Jun 18, 2020 4:02pm

113 Views

Post# 31166549

RE:Presentation

Thanks for sharing - data is really promising. But, the deck they assembled looks like it was put together by a first year Masters student...I think they missed an opportuntiy to demonstrate data from pre-clinical models showing that cellular composition within in the pouch is predictive of efficacy in blood glucose lowering...hopefully they release additional endpoint data soon.

R

Bullboard Posts

5 steps to mastering risk management in the stock market